• LDS
  • /Medical Tests
  • /Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies

Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies
Medical Test

Diseases (1)
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Overview
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Clinical Utility
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Interpretation
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Reference Ranges
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Methodology
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Specimen Collection
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Additional Testing
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Turnaround Time
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

CPT
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

LOINC
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

ICD10
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Additional ICD10
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

References
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.

Panel Test Components
Access to Optical Genome Mapping for copy number alterations, aneuploidy, and balanced/complex structural rearrangements in Hematological Malignancies is restricted.